Ovid Therapeutics (1OT.F) Q1 2026 Earnings

18MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.15
-0.08
-0.01
0.05

Details

Expected EPS
-0.10213590880000001
Actual EPS
0.0523416
Surprise EPS
0.15
Surprise Percent
+151.25%

Description

Ovid Therapeutics (1OT.F) has reported earnings of 0.0523416 per share for Q1 2026.

0 Comments

Share your thoughts